x

Science

AstraZeneca Buying Drug Developer Alexion for $39 Billion

December 12, 2020

LONDON — Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion.

Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said Saturday it's using a combination of cash and shares for the acquisition of Boston-based Alexion Pharmaceuticals Inc. 

The boards of both companies unanimously approved the transaction, which still needs regulatory and shareholder approval. The deal is expected to close in the third quarter of 2021. 

"This acquisition allows us to enhance our presence in immunology," AstraZeneca CEO Pascal Soriot said in a statement. 

AstraZeneca and Oxford University have jointly developed a coronavirus vaccine that British and Canadian regulators are assessing, alongside a rival effort by U.S. drugmaker Pfizer and Germany's BioNTech that has already earned some emergency approvals, and another by U.S. biotechnology company Moderna. 

RELATED

LONDON — Tesla is turning to Mozambique for a key component in its electric car batteries in what analysts believe is a first-of-its-kind deal designed to reduce its dependence on China for graphite.

Top Stories

United States

I’ve only ‘met’ Zaferios G Caragianades once in the pages of history.

Politics

Ambassador Dimitrios Tsikouris (JD, MA) has a 36-year-long career in the Greek Diplomatic Service with assignments in Germany, the United Nations, New Orleans, Washington, DC, NATO Defense College in Rome, Italy, Iran, Belgium, Indonesia, Malaysia, and ASEAN.

Politics

ATHENS – Growing violence on Greek campuses will be dealt with, Prime Minister Kyriakos Mitsotakis said in a pledge to root out offenders who are allowed to stay in school despite causing problems.

Video

Jill Biden: I Didn’t Expect “Healing Role” as First Lady

LAS VEGAS — Her husband campaigned to help unite the country, but Jill Biden says "healing" a nation wounded by a deadly pandemic, natural and other disasters and deep political polarization is among her chief roles as first lady, too.